This work reports on dyeing of nylon/elastane fabric with water-soluble phthalocyanines ( 1-4 ) bearing quinoline 5-sulfonic acid substituents on the peripheral or nonperipheral positions and determining the antibacterial efficiency of the phthalocyanine compounds and the dyed nylon/elastane fabrics. The light, washing, water, perspiration, and rubbing fastness properties of nylon/elastane fabrics dyed with phthalocyanines were also determined. The results showed that all dyed fabrics showed very good wet fastness values. The lightfastness value of the nylon/elastane fabric dyed with phthalocyanine dye ( 1 ) showed a much better value than the others. Also, the antibacterial efficiencies of the dyed nylon fabrics and the dye compounds were investigated against a gram-negative ( Escherichia coli ) and a grampositive ( Staphylococcus aureus ) bacteria by using disc diffusion method. The results showed that the dyed nylon/elastane fabrics and the compounds exhibited antibacterial activities against both bacteria.
Breast cancer remains one of the most prevalent types of cancer among women globally, contributing significantly to cancer-related mortality. Despite advancements in treatment, many cases continue to exhibit resistance to chemotherapy, radiotherapy, and hormonal therapies, often resulting in drug resistance, high recurrence rates, and severe side effects. Consequently, the role of the natural food components in cancer prevention and treatment is gaining increasing attention in modern medicine. This study focuses on quercetin, a phytochemical compound, and its effects on the breast cancer cell line MCF-7. Specifically, the study has investigated changes in the expression of miR-15a and miR-34a—microRNAs (miRNAs) known to regulate gene expression at the post-transcriptional level—and the P53 gene, which is critically involved in apoptosis. The analysis was performed using quantitative polymerase chain reaction (qPCR) and Western blot techniques. The results demonstrated that quercetin treatment at concentrations of 40 µM and 80 µM led to a 1.34-fold and 2.73-fold increase in P53 gene expression, respectively. Additionally, the tumor suppressor miRNA miR-15a showed expression changes of 1.48-fold and 1.69-fold at the same quercetin concentrations. Similarly, miR-34a expression levels increased by 1.23-fold and 1.39-fold at 40 µM and 80 µM, respectively. These findings suggest that dietary phytochemicals, such as quercetin, may have therapeutic potential by modulating miRNA expression and targeting the p53 pathway. In conclusion, quercetin emerges as a promising natural therapeutic agent for breast cancer, warranting further in vivo studies and clinical trials to confirm its efficacy and explore its potential as a part of combination therapies.